Skip to main content

dexlansoprazole

Generic: DEXLANSOPRAZOLE·Brand: DEXILANT, DEXILANT SOLUTAB, DEXLANSOPRAZOLE, Dexilant

dexlansoprazole: 2 clinical trials tracked.

dexlansoprazole evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about dexlansoprazole, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (2)

A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE

NCT02615184Registry updated 2026-05-06·Phase 2
Terminated

Primary endpoint: Percentage of Participants with Healing of EE by Week 8

InterventionalRandomizedquadruple24 targetStarted 2023-05Completion 2026-0425 sites · Canada, Colombia, Mexico, Poland…Takeda

A Phase 2, Double-Blind, 12-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 2 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease

NCT02616302Registry updated 2026-07-29·Phase 2
Completed

Primary endpoint: Percentage of Days Without Hurting or Burning in the Stomach, Chest or Throat Over the 12 Weeks of Treatment

InterventionalRandomizedquadruple71 enrolledStarted 2023-02Completion 2026-0718 sites · Canada, Colombia, Mexico, Poland…Takeda